New Zealand markets open in 8 hours 19 minutes

Astria Therapeutics, Inc. (ATXS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.80+0.03 (+0.31%)
As of 09:35AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 535.95M
Enterprise value 385.07M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.63
Enterprise value/revenue N/A
Enterprise value/EBITDA -5.68

Trading information

Stock price history

Beta (5Y monthly) 0.71
52-week change 3-22.77%
S&P500 52-week change 325.77%
52-week high 316.90
52-week low 34.26
50-day moving average 312.53
200-day moving average 39.01

Share statistics

Avg vol (3-month) 31.03M
Avg vol (10-day) 3960.42k
Shares outstanding 554.91M
Implied shares outstanding 654.91M
Float 836.14M
% held by insiders 10.49%
% held by institutions 185.96%
Shares short (15 Apr 2024) 45.05M
Short ratio (15 Apr 2024) 43.32
Short % of float (15 Apr 2024) 49.55%
Short % of shares outstanding (15 Apr 2024) 49.19%
Shares short (prior month 15 Mar 2024) 42.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 331 Dec 2018
Ex-dividend date 4N/A
Last split factor 21:6
Last split date 320 Aug 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-17.47%
Return on equity (ttm)-31.40%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-72.89M
Diluted EPS (ttm)-2.42
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)246.53M
Total cash per share (mrq)4.49
Total debt (mrq)329k
Total debt/equity (mrq)0.14%
Current ratio (mrq)21.73
Book value per share (mrq)3.60

Cash flow statement

Operating cash flow (ttm)-68.44M
Levered free cash flow (ttm)-36.52M